A 1999 clinical study that Merck & Co Inc (MRK.N) said was done to test side effects of its now-withdrawn painkiller Vioxx was done primarily to support a marketing campaign before its launch, according to researchers.
The real aim of the study, called ADVANTAGE, was to promote prescription of the new medicine when it became available -- a so-called "seeding" project -- U.S. researchers said on Tuesday.
"Documentary evidence shows that ADVANTAGE is an example of marketing framed as science," they wrote in the journal Annals of Internal Medicine.
Kevin Hill, a psychiatrist at McLean Hospital in Belmont, Mass., and colleagues said the findings showed how studies masquerading as clinical science could be used to bolster marketing plans.
The Trump administration is facing a legal complaint from a group of government employees affected by...
Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —...
The Department of Health and Human Services is freezing all childcare payments to all states, an...
US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss...
